Mallinckrodt Takes Out Sucampo in Surprising $1.2B Deal Post author:Sam Post published:December 26, 2017 Post category:BioPharma Mallinckrodt picks up Sucampo’s Amitiza as well as two other pipeline compounds. Source: BioSpace You Might Also Like <b>Elon Musk</b> Launches Neuroscience Startup to Plug AI Into Your Brain March 27, 2017 Johnson & Johnson Selling LifeScan Unit for $2.1 Billion March 15, 2018 Celgene to Create BioPharma Incubator on New Jersey R&D Site January 17, 2018
